| ALIOS | American Lifestyle Induced Obesity Syndrome |
| ALMS1 | Alström |
| ALR | Augmenter of liver regeneration |
| APOE2ki | Apolipoprotein E2 knock-in |
| CCl4 | Carbon tetrachloride |
| CD | Diet deficient for/low in choline |
| CDAA | Choline-deficient L-amino acid-defined diet |
| DIAMOND | Diet-induced animal model of non-alcoholic fatty liver disease |
| FLS | Fatty liver Shionogi |
| FXR | Farnesoid X receptor |
| Gank | Gankyrin |
| GFER | Growth Factor ERV1 homolog of Saccharomyces cerevisiae |
| HCC | Hepatocellular carcinoma |
| HFC | High-fat/high-cholesterol diet |
| HFD | High-fat diet |
| Ldlr | Low-density lipoprotein receptor |
| MAT1a | methionine adenosyltransferase 1A |
| MC4R | Melanocortin 4 receptor |
| MetS | Metabolic Syndrome |
| MS-NASH | Mice formerly known as FATZO/Pco |
| NAFLD | Non-alcoholic fatty liver disease |
| NASH | Non-alcoholic steatohepatitis |
| NEMO | NF-κB essential modulator |
| PNPLA3 | Patatin-like phospholipase domain-containing 3 |
| PPAR | Peroxisome proliferator-activated receptor |
| PTEN | Phosphatase and tensin homolog |
| T2D | Type 2 Diabetes |
| TAA | Thioacetamide |
| TM6SF2 | Transmembrane 6 superfamily member 2 |
| TNFα | Tumor necrosis factor α |
| TSOD | Tsumura-Suzuki Obese Diabetes |